Chimeric antigen receptor T-cell therapy for solid tumors
Chimeric antigen receptor (CAR) T cells are engineered constructs composed of synthetic receptors that direct T cells to surface antigens for subsequent elimination. Many CAR constructs are also manufactured with elements that augment T-cell persistence and activity. To date, CAR T cells have demons...
Main Authors: | Kheng Newick, Edmund Moon, Steven M Albelda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770516300456 |
Similar Items
-
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
by: Astero Klampatsa, et al.
Published: (2017-09-01) -
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
by: Erhao Zhang, et al.
Published: (2018-01-01) -
Chimeric antigen receptor T cells: a novel therapy for solid tumors
by: Shengnan Yu, et al.
Published: (2017-03-01) -
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01) -
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01)